Zkusit zdarma
Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc.

ABOS
Cena:
$ 2.51
+0.02 (0.80%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet

Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet

7:45 20-05-2026

Acumen Pharmaceuticals is a clinical-stage Alzheimer's biotech built around sabirnetug. I believe 20...

Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

14:20 14-05-2026

Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Tr...

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript

11:30 12-05-2026

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript...

Acumen Pharmaceuticals Q1 Earnings Call Highlights

Acumen Pharmaceuticals Q1 Earnings Call Highlights

9:08 12-05-2026

Acumen Pharmaceuticals NASDAQ: ABOS said its Phase 2 ALTITUDE-AD trial of sabirnetug remains on trac...

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

7:00 12-05-2026

NEWTON, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acum...

Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference

Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference

16:00 07-05-2026

NEWTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clini...

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026

16:00 05-05-2026

NEWTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acum...

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

10:36 31-03-2026

The heavy selling pressure might have exhausted for Acumen Pharmaceuticals (ABOS) as it is technical...

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

10:40 30-03-2026

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and ADC Therapeutics SA (ADCT) have performed compar...

Analysts Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Target Price at $7.00

Analysts Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Target Price at $7.00

3:17 30-03-2026

Shares of Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) have been assigned a consens...

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call Transcript

18:25 26-03-2026

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call Transcript...

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights

7:00 26-03-2026

NEWTON, Mass., March 26, 2026 (GLOBE NEWSWIRE) --  Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“...

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026

16:00 19-03-2026

NEWTON, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Ac...

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

6:30 16-03-2026

NEWTON, Mass., March 16, 2026 (GLOBE NEWSWIRE) --  Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“...

Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

5:30 14-01-2026

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) CEO Daniel Joseph Oconnell sold 12,941...

Matt Zuga Sells 6,888 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

Matt Zuga Sells 6,888 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

4:48 14-01-2026

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) CFO Matt Zuga sold 6,888 shares of Acu...

Daniel Joseph Oconnell Sells 8,143 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

Daniel Joseph Oconnell Sells 8,143 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

4:48 14-01-2026

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) CEO Daniel Joseph Oconnell sold 8,143 ...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages

5:24 11-01-2026

Shares of Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) have earned an average ratin...

Financial Review: Acumen Pharmaceuticals (NASDAQ:ABOS) versus Bolt Biotherapeutics (NASDAQ:BOLT)

Financial Review: Acumen Pharmaceuticals (NASDAQ:ABOS) versus Bolt Biotherapeutics (NASDAQ:BOLT)

2:08 15-12-2025

Acumen Pharmaceuticals (NASDAQ: ABOS - Get Free Report) and Bolt Biotherapeutics (NASDAQ: BOLT - Get...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives $6.75 Average Target Price from Analysts

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives $6.75 Average Target Price from Analysts

3:29 25-11-2025

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) has been given a consensus rating of "...

close

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

26-08-2025
NEWTON, MASS., AUG. 26, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

12-08-2025
NEWTON, MASS., AUG. 12, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (“ACU...
Více zde

ACUMEN PHARMACEUTICALS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 12, 2025

05-08-2025
NEWTON, MASS., AUG. 05, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (“ACU...
Více zde

JCR PHARMACEUTICALS AND ACUMEN PHARMACEUTICALS ANNOUNCE COLLABORATION TO DEVELOP THERAPY FOR ALZHEIMER'S DISEASE, ENABLED BY J-BRAIN CARGO® TECHNOLOGY PLATFORM

15-07-2025
HYOGO, JAPAN--(BUSINESS WIRE)--JCR PHARMACEUTICALS CO., LTD. (TSE 4552; JCR), A GLOBAL SPECIALTY BIO...
Více zde

ACUMEN PHARMACEUTICALS TO PRESENT STUDIES ON COST SAVINGS ASSOCIATED WITH USE OF PTAU217 SCREENING ASSAY IN PHASE 2 ALTITUDE-AD STUDY AND SABIRNETUG OLIGOMER-SELECTIVITY AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC®) 2025

10-07-2025
NEWTON, MASS., JULY 10, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLI...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE BANK OF AMERICA HEALTHCARE CONFERENCE

07-05-2025
NEWTON, MASS., MAY 07, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLINI...
Více zde

ACUMEN PHARMACEUTICALS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 13, 2025

06-05-2025
NEWTON, MASS., MAY 06, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (“ACUM...
Více zde

ACUMEN PHARMACEUTICALS SHOWCASES PTAU217 TRIAL SCREENING PROGRESS IN PHASE 2 ALTITUDE-AD TRIAL AND PRECLINICAL RESEARCH METHODS AT AD/PD 2025 AND AAN ANNUAL MEETING

02-04-2025
BIOMARKER RESULTS FROM PHASE 1 INTERCEPT-AD TRIAL OF SABIRNETUG IN PATIENTS WITH EARLY ALZHEIMER'S D...
Více zde

ACUMEN PHARMACEUTICALS TO REPORT FOURTH QUARTER AND YEAR-END 2024 FINANCIAL RESULTS ON MARCH 27, 2025

20-03-2025
NEWTON, MASS., MARCH 20, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (“AC...
Více zde

ACUMEN PHARMACEUTICALS CEO DISCUSSES NOVEL TARGETED THERAPIES FOR ALZHEIMER'S

18-03-2025
NEW YORK, MARCH 18, 2025 (GLOBE NEWSWIRE) -- TODAY'S MARKETPLACE (TMP) IS PROUD TO ANNOUNCE A FEATUR...
Více zde

ACUMEN PHARMACEUTICALS TO PRESENT DURING INTERNATIONAL CONFERENCE ON ALZHEIMER'S AND PARKINSON'S DISEASES 2025 AND AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

12-03-2025
ORAL PRESENTATIONS WILL HIGHLIGHT THE IMPLEMENTATION OF A VALIDATED RESEARCH-USE PLASMA PTAU217 ASSA...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

10-03-2025
NEWTON, MASS., MARCH 10, 2025 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLI...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE 7TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE

26-11-2024
NEWTON, MASS., NOV. 26, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE STIFEL HEALTHCARE CONFERENCE

11-11-2024
NEWTON, MASS., NOV. 11, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE UBS GLOBAL HEALTHCARE CONFERENCE

06-11-2024
NEWTON, MASS., NOV. 06, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS PRESENTS INNOVATIVE TRIAL SCREENING ADVANCEMENTS UTILIZING PTAU217 ASSAY IN PHASE 2 STUDY OF SABIRNETUG FOR EARLY ALZHEIMER'S DISEASE AT THE 17TH ANNUAL CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE

31-10-2024
NEWTON, MASS., OCT. 31, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS TO DELIVER LATE-BREAKING PRESENTATION AT 17TH ANNUAL CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE

23-10-2024
- PRESENTATION TO FOCUS ON USE OF VALIDATED PTAU217 ASSAY IN PARTICIPANT SCREENING PROCESS FOR PHASE...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE BANK OF AMERICA CNS THERAPEUTICS VIRTUAL CONFERENCE

30-09-2024
NEWTON, MASS., SEPT. 30, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLI...
Více zde

ACUMEN PHARMACEUTICALS TO HOST VIRTUAL R&D DAY ON OCT. 2, 2024

25-09-2024
NEWTON, MASS., SEPT. 25, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (“AC...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTOR CONFERENCE

03-09-2024
NEWTON, MASS., SEPT. 03, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLI...
Více zde

ACUMEN PHARMACEUTICALS TO REPORT SECOND QUARTER RESULTS ON AUGUST 13, 2024

06-08-2024
NEWTON, MASS., AUG. 06, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (“ACU...
Více zde

ACUMEN PHARMACEUTICALS ANNOUNCES FIRST SUBJECT DOSED IN PHASE 1 STUDY OF SUBCUTANEOUS SABIRNETUG (ACU193) FOR EARLY ALZHEIMER'S DISEASE

29-07-2024
NEWTON, MASS., JULY 29, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS PRESENTS PATIENT EXPERIENCE AND BIOMARKER DATA FROM PHASE 1 INTERCEPT-AD STUDY AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC®) 2024

28-07-2024
NEWTON, MASS., JULY 28, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), A CLIN...
Více zde

ACUMEN PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

14-05-2024
CHARLOTTESVILLE, VA., MAY 14, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE H.C. WAINWRIGHT 2ND ANNUAL BIOCONNECT INVESTOR CONFERENCE

13-05-2024
CHARLOTTESVILLE, VA., MAY 13, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), ...
Více zde

ACUMEN PHARMACEUTICALS TO PARTICIPATE IN THE 2024 BANK OF AMERICA HEALTHCARE CONFERENCE

08-05-2024
CHARLOTTESVILLE, VA., MAY 08, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), ...
Více zde

ACUMEN PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN ALTITUDE-AD, A PHASE 2 CLINICAL TRIAL OF SABIRNETUG (ACU193) IN EARLY ALZHEIMER'S DISEASE

08-05-2024
CHARLOTTESVILLE, VA., MAY 08, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS), ...
Více zde

ACUMEN PHARMACEUTICALS TO REPORT FIRST QUARTER RESULTS ON MAY 14, 2024

07-05-2024
CHARLOTTESVILLE, VA., MAY 07, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS) (...
Více zde

ACUMEN PHARMACEUTICALS PRESENTS FIRST COMPREHENSIVE CLINICAL AND BIOMARKER DATA FOR SABIRNETUG (ACU193) AT AMERICAN ACADEMY OF NEUROLOGY 2024 ANNUAL MEETING

16-04-2024
CHARLOTTESVILLE, VA., APRIL 16, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICALS, INC. (NASDAQ: ABOS)...
Více zde

ACUMEN PHARMACEUTICALS COLLABORATES WITH LONZA TO ADVANCE SABIRNETUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE

04-04-2024
CHARLOTTESVILLE, VA. AND BASEL, SWITZERLAND, APRIL 04, 2024 (GLOBE NEWSWIRE) -- ACUMEN PHARMACEUTICA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-11-12 00:00:008-KStáhnout
2025-11-12 00:00:0010-QStáhnout
2025-11-10 00:00:008-KStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-07-15 01:00:008-KStáhnout
2025-07-15 00:00:008-KStáhnout
2025-06-05 01:00:008-KStáhnout
2025-06-05 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-27 00:00:008-KStáhnout
2025-03-27 00:00:0010-KStáhnout
2025-03-26 23:00:008-KStáhnout
2025-03-26 23:00:0010-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-06-05 01:00:008-KStáhnout
2024-06-05 00:00:008-KStáhnout
2024-05-14 01:00:008-KStáhnout
2024-05-14 01:00:0010-QStáhnout
2024-05-14 00:00:008-KStáhnout
2024-05-14 00:00:0010-QStáhnout
2024-03-26 00:00:008-KStáhnout
2024-03-26 00:00:0010-KStáhnout
2024-03-25 23:00:008-KStáhnout
2024-03-25 23:00:0010-KStáhnout
2024-03-19 00:00:008-KStáhnout
2024-03-18 23:00:008-KStáhnout
2024-02-01 00:00:008-KStáhnout
2024-01-31 23:00:008-KStáhnout
2024-01-12 00:00:008-KStáhnout
2024-01-11 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-04 00:00:008-KStáhnout
2023-12-03 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-08 23:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-07-20 01:00:008-KStáhnout
2023-07-20 00:00:008-KStáhnout
2023-07-17 01:00:008-KStáhnout
2023-07-17 00:00:008-KStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-27 01:00:008-KStáhnout
2023-04-27 00:00:008-KStáhnout
2023-03-27 01:00:008-KStáhnout
2023-03-27 01:00:0010-KStáhnout
2023-03-27 00:00:008-KStáhnout
2023-03-27 00:00:0010-KStáhnout
2023-03-15 00:00:008-KStáhnout
2023-03-14 23:00:008-KStáhnout
2023-02-01 00:00:008-KStáhnout
2023-01-31 23:00:008-KStáhnout
2023-01-04 00:00:008-KStáhnout
2023-01-03 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-10-24 01:00:008-KStáhnout
2022-10-24 00:00:008-KStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 01:00:0010-QStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-15 00:00:0010-QStáhnout
2022-08-01 01:00:008-KStáhnout
2022-08-01 00:00:008-KStáhnout
2022-06-21 01:00:008-KStáhnout
2022-06-21 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 01:00:0010-QStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-16 00:00:0010-QStáhnout
2022-03-28 01:00:008-KStáhnout
2022-03-28 01:00:0010-KStáhnout
2022-03-28 00:00:008-KStáhnout
2022-03-28 00:00:0010-KStáhnout
2022-01-03 00:00:008-KStáhnout
2022-01-02 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-15 00:00:0010-QStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-14 23:00:0010-QStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-09 23:00:008-KStáhnout
2021-10-07 01:00:008-KStáhnout
2021-10-07 00:00:008-KStáhnout
2021-08-31 01:00:008-KStáhnout
2021-08-31 00:00:008-KStáhnout
2021-08-16 01:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:008-KStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-07-07 01:00:008-KStáhnout
2021-07-07 00:00:008-KStáhnout
preloader